Vincerx Pharma, Inc. Restructuring Charges
Vincerx Pharma, Inc. reported Restructuring Charges of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-03-29
- Vincerx Pharma, Inc. restructuring charges for the quarter ending 2023-12-31 was $0.00.
- Vincerx Pharma, Inc. restructuring charges for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Vincerx Pharma, Inc. restructuring charges for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Vincerx Pharma, Inc. restructuring charges for the quarter ending 2023-03-31 was $0.00.
- Vincerx Pharma, Inc. restructuring charges for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Vincerx Pharma, Inc. restructuring charges for fiscal 2022 was $2.47M.
- Vincerx Pharma, Inc. restructuring charges for fiscal 2021 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | $0.00 10-K · filed 2024-03-29 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-29 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | $1.31M derived: sum of 4 quarters · filed 2024-03-29 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $1.31M derived: sum of 3 quarters · filed 2024-03-29 | $2.47M derived: sum of 4 quarters · filed 2024-03-29 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.31M derived: sum of 2 quarters · filed 2024-03-29 | $2.47M derived: sum of 3 quarters · filed 2024-03-29 | $2.47M 10-K · filed 2024-03-29 |
| 2022-09-30 | $1.31M 10-Q · filed 2023-11-14 | $2.47M derived: sum of 2 quarters · filed 2023-11-14 | $2.47M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.16M 10-Q · filed 2023-08-07 | $1.16M 10-Q · filed 2023-08-07 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 |